Chong Kun Dang Pharma disclosure shows Rhee Jang-Han stake unchanged at 40.15%

• A Chong Kun Dang stake disclosure showed no change in total holdings: 5,542,063 shares, unchanged at 40.15% as of Sept. 30.
• The update reflected revised share-pledge terms by related parties, lifting pledged shares to 253,919 from 244,618, or 1.84%.
• The change followed partial repayment of margin loans tied to pledged shares, with contract terms amended on Sept. 21.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Chong Kun Dang Pharmaceutical Corporation published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930000763), on September 30, 2026, and is solely responsible for the information contained therein.